Change in Plasma Cryptococcal Antigen Titer Is Not Associated With Survival Among Human Immunodeficiency Virus-infected Persons Receiving Preemptive Therapy for Asymptomatic Cryptococcal Antigenemia

Affiliations

• ¹ Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis.
• ² Department of Research, Infectious Diseases Institute, Makerere University, Kampala, Uganda.
• ³ Division of Global Human Immunodeficiency Virus and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
• ⁴ Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
• ⁵ Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.